{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:55:25Z","timestamp":1775019325682,"version":"3.50.1"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Premenopausal women at familial or hereditary risk of ovarian cancer must weigh the risks and benefits of risk-reducing surgery. How they navigate this decision is not well understood.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To assess the factors that motivate women to seek risk-reducing surgery for ovarian cancer.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n A discrete choice experiment enrolled premenopausal women seeking genetic testing for ovarian cancer risk at 2 tertiary-level cancer centers between August 2019 and January 2022. The experiment was conducted twice, once just prior to pretest counseling and again approximately 2 months later, after receiving results of genetic testing. Data analysis was conducted between June 2022 through January 2026.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Conjoint analysis to assess factors influencing cancer-prevention decisions in women with risk of familial and hereditary ovarian cancer. Conjoint analysis was used to investigate which attributes were the most salient for women when considering treatment scenarios, with demographic and clinical data as modifiers. Participants were asked to choose between sets of randomly permuted scenarios specifying type of treatment, risk and age of ovarian cancer, risk of heart disease and osteoporosis, and features of menopause.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The participants included 355 women (median age, 37 years [range, 21-55 years]): 10.4% were Black, 7.6% were Hispanic, 85.1% were White, and 79.2% were college graduates. Family history of breast cancer was reported by 45.1%, ovarian cancer by 13.0%, and 11.3% had a personal history of breast cancer. Women preferred risk-reducing salpingo-oophorectomy (RRSO) to risk-reducing salpingectomy (RRS) or observation (odds ratio [OR],\u20091.24; 95% CI, 1.10-1.39). Differences in osteoporosis (OR,\u20090.83; 95% CI, 0.78-0.89) and heart disease (OR,\u20090.78; 95% CI, 0.73-0.84) risks affected choices. Preferences favored natural menopause (OR,\u20091.21; 95% CI, 1.11-1.33) and milder menopausal symptoms (OR,\u20090.66; 95% CI, 0.61-0.70). Family history of ovarian cancer increased preference for RRSO (OR,\u20091.26; 95% CI, 1.05-1.52), with a reduced effect in older women. Personal breast cancer history, ancestry, and genetic test results were not significant factors.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This survey study using conjoint analysis highlights the ability of women to weigh competing risks in reducing ovarian cancer. Counseling models that address decision complexity and incorporate personalized guidance are likely to improve the decision-making process.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.3404","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:30:20Z","timestamp":1774971020000},"page":"e263404","source":"Crossref","is-referenced-by-count":1,"title":["Personalized Decision-Making in Risk-Reducing Surgery of the Ovaries"],"prefix":"10.1001","volume":"9","author":[{"given":"Mary B.","family":"Daly","sequence":"first","affiliation":[{"name":"Department of Clinical Genetics, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian L.","family":"Egleston","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitlyn","family":"Lew","sequence":"additional","affiliation":[{"name":"Division of Cancer Genetics and Prevention, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Bealin","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Husband","sequence":"additional","affiliation":[{"name":"Division of Cancer Genetics and Prevention, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill E.","family":"Stopfer","sequence":"additional","affiliation":[{"name":"Division of Cancer Genetics and Prevention, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawel","family":"Przybysz","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Tchuvatkina","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ning","family":"Wong","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy E.","family":"Garber","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy R.","family":"Rebbeck","sequence":"additional","affiliation":[{"name":"Division of Cancer Genetics and Prevention, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"4","key":"zoi260136r1","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkaa029","article-title":"Penetrance of breast and ovarian cancer in women who carry a BRCA1\/2 mutation and do not use risk-reducing salpingo-oophorectomy: an updated meta-analysis.","volume":"4","author":"Chen","year":"2020","journal-title":"J Natl Cancer Inst Cancer Spectr"},{"issue":"23","key":"zoi260136r2","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"zoi260136r3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.breast.2021.12.005","article-title":"BRCA1\/2 testing for genetic susceptibility to cancer after 25 years: a scoping review and a primer on ethical implications.","volume":"61","author":"Petrova","year":"2022","journal-title":"Breast"},{"issue":"17","key":"zoi260136r4","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1093\/hmg\/ddu172","article-title":"The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population.","volume":"23","author":"Song","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"1","key":"zoi260136r5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ygyno.2021.10.072","article-title":"Probability of detecting germline BRCA1\/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysis.","volume":"164","author":"Witjes","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"15","key":"zoi260136r6","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"key":"zoi260136r7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ejca.2016.03.009","article-title":"Germline BRCA1\/2 mutation testing is indicated in every patient with epithelial ovarian cancer: a systematic review.","volume":"61","author":"Arts-de Jong","year":"2016","journal-title":"Eur J Cancer"},{"issue":"2","key":"zoi260136r8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"zoi260136r9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1158\/1940-6207.CAPR-14-0293","article-title":"Salpingectomy as a means to reduce ovarian cancer risk.","volume":"8","author":"Daly","year":"2015","journal-title":"Cancer Prev Res (Phila)"},{"issue":"2","key":"zoi260136r10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.47343","article-title":"Outcomes from opportunistic salpingectomy for ovarian cancer prevention.","volume":"5","author":"Hanley","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"5","key":"zoi260136r11","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1177\/0272989X07307270","article-title":"Communicating the uncertainty of harms and benefits of medical interventions.","volume":"27","author":"Politi","year":"2007","journal-title":"Med Decis Making"},{"key":"zoi260136r12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1472-6874-10-24","article-title":"Women\u2019s constructions of the \u2018right time\u2019 to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.","volume":"10","author":"Howard","year":"2010","journal-title":"BMC Womens Health"},{"issue":"13","key":"zoi260136r13","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/jama.2014.5985","article-title":"Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.","volume":"313","author":"Rebbeck","year":"2015","journal-title":"JAMA"},{"issue":"8","key":"zoi260136r14","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.","volume":"26","author":"Kauff","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"zoi260136r15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/ijgc-2022-003893","article-title":"Ovarian cancer onset across different BRCA mutation types: a view to a more tailored approach for BRCA mutated patients.","volume":"33","author":"Marchetti","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"zoi260136r16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1258\/mi.2008.008016","article-title":"Prophylactic oophorectomy in premenopausal women and long-term health.","volume":"14","author":"Shuster","year":"2008","journal-title":"Menopause Int"},{"issue":"1","key":"zoi260136r17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/bjc.2011.202","article-title":"Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT.","volume":"105","author":"Challberg","year":"2011","journal-title":"Br J Cancer"},{"issue":"1","key":"zoi260136r18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1161\/CIR.0b013e3182456d46","article-title":"Executive summary: heart disease and stroke statistics\u20142012 update: a report from the American Heart Association.","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"issue":"3 Pt 2","key":"zoi260136r19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/gme.0b013e318038d333","article-title":"Surgical menopause and cardiovascular risks.","volume":"14","author":"Lobo","year":"2007","journal-title":"Menopause"},{"issue":"2","key":"zoi260136r20","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.3390\/curroncol30020185","article-title":"The psychosocial impact of the decision to undergo risk-reducing salpingo-oophorectomy surgery in BRCA mutation carriers and the role of physician-patient communication.","volume":"30","author":"Alves-Nogueira","year":"2023","journal-title":"Curr Oncol"},{"issue":"3","key":"zoi260136r21","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/jgc4.1684","article-title":"Exploring the role of a multidisciplinary hereditary gynecologic oncology clinic in epithelial ovarian cancer risk-reducing surgical decision-making practices: a mixed-methods study.","volume":"32","author":"Casalino","year":"2023","journal-title":"J Genet Couns"},{"issue":"4","key":"zoi260136r22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1399-0004.2009.01329.x","article-title":"Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing.","volume":"77","author":"Skytte","year":"2010","journal-title":"Clin Genet"},{"issue":"6","key":"zoi260136r23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-076876","article-title":"Decision aids for female BRCA mutation carriers: a scoping review.","volume":"14","author":"McGarrigle","year":"2024","journal-title":"BMJ Open"},{"issue":"4","key":"zoi260136r24","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jval.2016.04.004","article-title":"Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR Conjoint Analysis Good Research Practices Task Force.","volume":"19","author":"Hauber","year":"2016","journal-title":"Value Health"},{"issue":"2","key":"zoi260136r25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/hec.1697","article-title":"Discrete choice experiments in health economics: a review of the literature.","volume":"21","author":"de Bekker-Grob","year":"2012","journal-title":"Health Econ"},{"issue":"7248","key":"zoi260136r26","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1136\/bmj.320.7248.1530","article-title":"Using conjoint analysis to elicit preferences for health care.","volume":"320","author":"Ryan","year":"2000","journal-title":"BMJ"},{"issue":"9","key":"zoi260136r27","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/MLR.0b013e31829faffd","article-title":"Cancer patients\u2019 trade-offs among efficacy, toxicity, and out-of-pocket cost in the curative and noncurative setting.","volume":"51","author":"Wong","year":"2013","journal-title":"Med Care"},{"issue":"2","key":"zoi260136r28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/01.gme.0000218683.97338.ea","article-title":"Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis.","volume":"13","author":"Atsma","year":"2006","journal-title":"Menopause"},{"issue":"3","key":"zoi260136r30","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1090\/S0002-9947-1943-0012401-3","article-title":"Tests of statistical hypotheses concerning several parameters when the number of observations is large.","volume":"54","author":"Wald","year":"1943","journal-title":"Trans Am Math Soc"},{"key":"zoi260136r31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ygyno.2023.04.006","article-title":"Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: a systematic review of the literature.","volume":"173","author":"Perez","year":"2023","journal-title":"Gynecol Oncol"},{"issue":"2","key":"zoi260136r32","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ygyno.2014.12.031","article-title":"Risk-reducing salpingectomy with delayed oophorectomy in BRCA1\/2 mutation carriers: patients\u2019 and professionals\u2019 perspectives.","volume":"136","author":"Arts-de Jong","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"6","key":"zoi260136r33","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1002\/jgc4.1265","article-title":"Genetic counseling service delivery models in the United States: assessment of changes in use from 2010 to 2017.","volume":"29","author":"Greenberg","year":"2020","journal-title":"J Genet Couns"},{"issue":"2","key":"zoi260136r34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2217\/cer.13.94","article-title":"Patient-Centered Outcomes Research Institute seeks to find out what works best by involving \u2018end-users\u2019 from the beginning.","volume":"3","author":"Selby","year":"2014","journal-title":"J Comp Eff Res"},{"issue":"2","key":"zoi260136r35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1136\/jmedgenet-2020-107501","article-title":"Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study.","volume":"59","author":"Gaba","year":"2022","journal-title":"J Med Genet"},{"key":"zoi260136r29","doi-asserted-by":"crossref","DOI":"10.1002\/0471249688","volume-title":"Categorical Data Analysis","author":"Agresti","year":"2002"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2847139\/daly_2026_oi_260136_1774363835.53693.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:30:21Z","timestamp":1774971021000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2847139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.3404","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]}}}